Street View
Street View — Estimate Revision Momentum
The consensus is moving sharply downward following MAPMYINDIA's Q3 FY26 earnings miss in mid-February, where the company reported EPS ₹3.30 versus the consensus estimate of ₹7.61 — a 57% shortfall that triggered an immediate reset of analyst expectations. While the consensus target remains at ₹1,681 (implying 56% upside from ₹1,077.85), this target has not yet been formally revised by most of the coverage universe. The street is waiting for Q4 FY26 results (expected May–June 2026) to assess whether management's reiterated 35% EBITDA margin guidance and promised "stronger Q4 growth" are credible — making the next print a binary event for both near-term ratings and FY27 estimate resets.
Street View in One Page
Consensus Buy Rating (%)
Consensus Target (₹)
Implied Upside (%)
Estimate revision direction: FALLING — EPS cut 40% post-Q3 miss.
Consensus snapshot (as of May 11, 2026): Seven analysts cover MAPMYINDIA with an average price target of ₹1,681 (range ₹945–₹1,850), versus current price ₹1,077.85. Rating distribution is 3 Strong Buy, 2 Buy, 1 Accumulate, 1 Sell — 57% of coverage is bullish. Estimate revision direction is FALLING following the 57% EPS miss in Q3 FY26 (Feb 13, 2026). The FY26 consensus revenue growth of 11.9% and profit growth of 0.3% imply a near-complete earnings stall. Next catalyst: Q4 FY26 results (May–June 2026) will be binary — management has promised a 35% full-year EBITDA margin and stronger Q4 growth after a weak Q3, but the execution bar is exceptionally high.
Consensus Snapshot
The bifurcation between revenue and earnings is striking. FY26–FY27 revenue consensus has risen modestly (11.6% CAGR, fueled by order book conversion expectations), but EPS has been slashed by 40% in three months. EBITDA margin estimates have been cut 300–330 basis points. The gap reflects two drivers: (1) Q3 FY26 revealed that the cost structure is higher than expected — management launched eight JVs and acquisitions in H2 FY26, front-loading P&L charges. (2) The near-term consensus assumes these investments will mature only in FY27–FY28, leaving FY26 earnings depressed. A successful Q4 (validating 35% margin guidance) could stabilize FY27 estimates and trigger some modest upside revision; a miss would trigger a fresh downgrade wave.
Rating Distribution & Target Prices
Bullish sentiment dominates the coverage universe (71% of analysts), but the quality of that bullish view has deteriorated sharply post-Q3 miss. The single documented recent rating action is Elara Capital on Feb 18, 2026, which reduced its target price from prior levels but maintained a Buy rating — a nuanced call that implies the stock is attractive on a 12-month basis but near-term risk/reward is now balanced rather than skewed upside.
The consensus target of ₹1,681 implies 56% upside, but this figure has not been formally reset since the Q3 miss. Elara Capital's ₹2,273 target (111% upside) is the highest visible on the street and reflects a more optimistic view of post-margin-investment payoff. The single documented sell-side bear (₹945) prices in persistent margin compression and slower-than-expected order book conversion.
Estimate Revision Trend
The revision sequence is unambiguous: FY26 EPS was cut 40% in three weeks post-Q3 (from ₹47 estimate to ₹29 actual + near-term cut). The EBITDA margin estimate fell 330 bps. The May 11 figures reflect a stabilized consensus after the initial shock — analysts have not yet reset FY27 estimates, as they are waiting for Q4 FY26 results to signal whether the company's margin guidance is credible. The plateau in May suggests the sell-side is in a holding pattern, not actively raising or lowering estimates until the next catalyst fires.
Revision momentum is clearly NEGATIVE. EPS estimates for FY26–FY27 have been cut 40%, with no material reversal visible despite a 4× higher order book. Analyst sentiment remains constructive (71% buy-rated) but conviction has weakened — the consensus target has not been formally lowered yet, suggesting the street is assuming near-term pain is temporary and Q4 will restore narrative credibility.
Recent Rating Actions & Sentiment Shifts
The key finding: There is only one documented formal rating action in the last 90 days — Elara Capital's maintenance of Buy on Feb 18, 2026, after cutting its target price. This is not an upgrade; it is a downgrade-with-hold. The broader sell-side consensus has responded to the Q3 miss with directional EPS cuts and lower margin assumptions, but has not yet issued a wave of formal downgrades or rating reductions. This gap is meaningful: it suggests the street views the Q3 result as a near-term execution stumble (project timing, JV cost front-loading) rather than a structural impairment. Q4 FY26 results will be the litmus test. If management delivers the promised 35% margin and strong growth, expect rating revisions upward and price-target restorations. If Q4 disappoints, expect a downgrade cascade and fresh FY27 estimate cuts.
Short Interest & Borrow Dynamics
Indian equities do not report standardized short interest data equivalent to US market conventions (no SEC filing requirement, no centralized borrow registry). Informal indicators suggest short interest is minimal in MAPMYINDIA — consistent with a small-cap liquid stock with modest institutional short positioning. The lack of significant short interest removes squeeze risk but also signals that bearish investors have expressed their view through sales rather than shorts, limiting a reflexive short-covering rally if sentiment turns positive.
Short interest data unavailable for Indian equities. Formal short-interest reporting does not exist on NSE/BSE. Informal market signals suggest minimal shorting activity, indicating bears are express pessimism through selling rather than borrowing. This removes upside catalyst from short-covering but also reflects that bearish thesis is not crowded.
What the Street Will Watch Next
The immediate near-term catalyst is unambiguously Q4 FY26 results in May–June 2026. The consensus assumes management's reiterated 35% EBITDA margin and "stronger Q4 growth" are achievable. If achieved, analyst targets will likely be reset upward 10–20%, triggering a relief rally. If missed, the stock faces a fresh downgrade wave and FY27 estimate reset. The second high-impact event is order book composition and conversion schedule disclosure — the ₹1,770 Cr backlog is the bull-case anchor, but its segment breakdown (automotive vs. government vs. enterprise), tenure, and revenue recognition schedule remain opaque. Unresolved longer-dated catalysts include the Ola Maps lawsuit (no injunction to date) and the GST penalty appeal outcome.
Where This Report's Evidence Diverges from Consensus
The consensus assumes MapmyIndia's Q3 stumble is a project-timing or JV-cost artifact that will reverse in Q4–FY27 as new ventures mature and order backlog converts. Our evidence surfaces additional governance and narrative-credibility risks not fully priced in: (1) Governance deficit. The attempted B2C spinoff in Dec 2024 (reversed under investor pressure, stock +16% on cancellation) and the abandoned ₹500 Cr QIP approved in Dec 2023 reveal a capital allocation pattern where management overcommits and then quietly reverses course without disclosure. The recent CEO exit and clustering of director resignations in Q1–Q2 2025 adds execution risk during a period when strong operational delivery is critical. (2) Narrative credibility decay. The Mappls Sky drone business, a flagship IPO pillar, has been abandoned without any public announcement across 16+ web sources. This is concrete evidence that management can pursue a multi-year strategic narrative without delivering and without disclosure. (3) Moat durability questions. While the consensus acknowledges Google Maps pricing pressure, it underweights the specific risk that Ola Maps' embedded relationship with India's gig-economy drivers provides a real-time data feedback loop that MapmyIndia cannot replicate at scale, and the unresolved lawsuit (no injunction to date) signals legal remedies may not be available. Our variant view flags that the order book may be lower-margin (government contracts, lower pricing) than the consensus assumes, which is critical given that Q3 EBITDA margin fell to 26% from 42% a year prior. The consensus target of ₹1,681 prices in a return to 40%+ margins by FY27–FY28, but the governance and moat evidence raises the probability this is not achieved. See the Variant Perception tab for the full divergence.
Summary
Consensus momentum is FALLING — EPS estimates cut 40% post-Q3 miss, with no formal recovery visible until Q4 results arrive. Rating distribution remains 71% bullish, but conviction has degraded; no major upgrades have offset the quiet downside revisions. The consensus target (₹1,681, +56% upside) has not been formally reset yet, likely because the street is waiting for Q4 FY26 results (May–June 2026) to judge whether management's reiterated 35% margin guidance is credible or if FY27 will require a fresh estimate reset. Short interest is minimal; borrow data unavailable for Indian equities. The next print is binary: credible Q4 results trigger a rating/target reset upward; a miss triggers downgrades and lower FY27 estimates.